DK0573542T3 - Imidazolderivater med antagonistisk aktivitet over for histamin-H3-receptoren - Google Patents

Imidazolderivater med antagonistisk aktivitet over for histamin-H3-receptoren

Info

Publication number
DK0573542T3
DK0573542T3 DK92906664.5T DK92906664T DK0573542T3 DK 0573542 T3 DK0573542 T3 DK 0573542T3 DK 92906664 T DK92906664 T DK 92906664T DK 0573542 T3 DK0573542 T3 DK 0573542T3
Authority
DK
Denmark
Prior art keywords
derivatives
histamine
receptor
antagonistic activity
activity against
Prior art date
Application number
DK92906664.5T
Other languages
Danish (da)
English (en)
Inventor
Henderikus Van Der Goot
Hendrik Timmerman
Original Assignee
Seed Capital Investments
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL9100365A external-priority patent/NL9100365A/nl
Application filed by Seed Capital Investments filed Critical Seed Capital Investments
Application granted granted Critical
Publication of DK0573542T3 publication Critical patent/DK0573542T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/94Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/95Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by nitrogen atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK92906664.5T 1991-02-27 1992-02-27 Imidazolderivater med antagonistisk aktivitet over for histamin-H3-receptoren DK0573542T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9100365A NL9100365A (nl) 1991-02-27 1991-02-27 Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
NL9101764A NL9101764A (nl) 1991-02-27 1991-10-22 Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3 receptor.

Publications (1)

Publication Number Publication Date
DK0573542T3 true DK0573542T3 (da) 1998-05-18

Family

ID=26646823

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92906664.5T DK0573542T3 (da) 1991-02-27 1992-02-27 Imidazolderivater med antagonistisk aktivitet over for histamin-H3-receptoren

Country Status (10)

Country Link
EP (1) EP0573542B1 (fr)
JP (1) JPH06505265A (fr)
AT (1) ATE159248T1 (fr)
AU (1) AU662135B2 (fr)
CA (1) CA2104946A1 (fr)
DE (1) DE69222757T2 (fr)
DK (1) DK0573542T3 (fr)
ES (1) ES2108107T3 (fr)
GR (1) GR3025554T3 (fr)
WO (1) WO1992015567A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9100365A (nl) * 1991-02-27 1992-09-16 Seed Capital Investments Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
DK0841922T3 (da) * 1995-05-30 2002-06-03 Gliatech Inc 1H-4(5)-substituerede imidazolderivater
US5652258A (en) * 1995-05-30 1997-07-29 Gliatech, Inc. 2-(4-imidazoyl) cyclopropyl derivatives
US6448282B1 (en) 1995-05-30 2002-09-10 Gliatech, Inc. 1H-4(5)-substituted imidazole derivatives
US6407132B1 (en) 1997-07-25 2002-06-18 James Black Foundation Limited Substituted imidazole derivatives and their use as histamine H3 receptor ligands
GB9803536D0 (en) 1998-02-19 1998-04-15 Black James Foundation Histamine H,receptor ligands
FR2781798B1 (fr) * 1998-07-28 2000-09-08 Synthelabo Derives de 4-phenyl- et de 4,5-diphenylimidazoles, leur preparation et leur application en therapeutique
AU3033100A (en) 1999-01-18 2000-08-01 Boehringer Ingelheim International Gmbh Substituted imidazoles, their preparation and use
US6908926B1 (en) 1999-04-16 2005-06-21 Novo Nordisk A/S Substituted imidazoles, their preparation and use
US6610721B2 (en) 2000-03-17 2003-08-26 Novo Nordisk A/S Imidazo heterocyclic compounds
US6437147B1 (en) 2000-03-17 2002-08-20 Novo Nordisk Imidazole compounds
WO2002013821A1 (fr) 2000-08-17 2002-02-21 Gliatech, Inc. Nouveaux imidazoles alicycliques utilises comme agents de h¿3?
CA2521000A1 (fr) * 2003-04-03 2004-10-21 Kyowa Hakko Kogyo Co., Ltd. Agent therapeutique et/ou curatif pour les douleurs nevropathiques
EP1707203A1 (fr) 2005-04-01 2006-10-04 Bioprojet Utilization des allkylamines sans imidazoles comme ligandes du recepteur histamine H3 pour le traitement de la maladie de Parkinson, de l'apnee obstructive du sommeil, de la demence vasculaire et de la demence avec corps de Lewy
EP1717233A1 (fr) 2005-04-29 2006-11-02 Bioprojet Ligands du récepteur histaminique H3 et leur application thérapeutique
EP1717235A3 (fr) 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines et leur utilisation comme ligands du récepteur histaminique H3
WO2013151982A1 (fr) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Méthodes et composés utiles pour traiter le prurit, et procédés d'identification desdits composés

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758145A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Iso-thio-urees et derives
GB1431589A (en) * 1973-07-13 1976-04-07 Smith Kline French Lab Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
US4262125A (en) * 1979-07-23 1981-04-14 American Home Products Corporation (1H-Imidazol-5-ylmethyl)isothioureas
DK221081A (da) * 1980-05-31 1981-12-01 Smith Kline French Lab Fremgangsmaade til fremstilling af heterocyklylalkylanidiner mellemprodukter til anvendelse ved denne fremgangsmaade og en fremgangsmaade til fremstilling af disse mellemprodukter
US4503139A (en) * 1983-05-09 1985-03-05 Polaroid Corporation Photographic products and processes and novel compounds
JPS6176465A (ja) * 1984-09-21 1986-04-18 Kanto Ishi Pharma Co Ltd 4−メチル−5−チオホルムアミジノメチルイミダゾ−ルジハイドロクロライド
DE3579000D1 (de) * 1985-04-02 1990-09-06 Heumann Pharma Gmbh & Co Imidazolylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
NL8601585A (nl) * 1986-06-19 1988-01-18 Vereniging Voor Christelijk Wetenschappelijk Onderwijs N-(2-gesubstitueerde alkyl)-n-imidazol-4-yl alkyl guanidine.
DE3631334A1 (de) * 1986-09-15 1988-03-17 Heumann Pharma Gmbh & Co Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
JPH06505265A (ja) 1994-06-16
WO1992015567A1 (fr) 1992-09-17
CA2104946A1 (fr) 1992-08-28
ES2108107T3 (es) 1997-12-16
ATE159248T1 (de) 1997-11-15
GR3025554T3 (en) 1998-03-31
DE69222757T2 (de) 1998-02-12
DE69222757D1 (de) 1997-11-20
EP0573542B1 (fr) 1997-10-15
EP0573542A1 (fr) 1993-12-15
AU1541892A (en) 1992-10-06
AU662135B2 (en) 1995-08-24

Similar Documents

Publication Publication Date Title
DK0573542T3 (da) Imidazolderivater med antagonistisk aktivitet over for histamin-H3-receptoren
ATE269290T1 (de) Benzoylderivate
IT8022637A0 (it) Uso di composti perfluorocarburici per il trattamento di lesioni,articoli e composizioni contenenti detti composti
DK0725782T3 (da) A1-adenosin-receptor-agonister og antiagonister
BR0013367A (pt) Uso de compostos, composição pesticida, e, método de combate a pestes em um local infestado ou sujeito a ser infestado com as mesmas
ATE158288T1 (de) Antiatherosklerotische und antithrombotische 1- benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on- derivate
ES2058093T3 (es) Agentes herbicidas y fungicidas a base de derivados de pirazolin-5-ona substituidos.
NZ240378A (en) Substituted thiazolidinedione derivatives; pharmaceutical compositions,
BR9712507A (pt) Derivados de aminotiazol, seu processo de preparo e as composições famacêuticas que os comtêm.
MA22540A1 (fr) Diaminophtalimides substitues et derives analogues .
DK76582A (da) Antimycotiske midler
ITTO930346A0 (it) Procedimento per la preparazione di derivati taurocolanici.
ITMI931685A1 (it) Derivati di polialchil-4-piperidinoli atti all'impiego come stabilizzanti per materiali organici
YU31191A (sh) Novi derivati beta-fenilizoserina njegovo dobijanje i primena
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
SE8700156D0 (sv) Kosmetiska kompositioner med hudlugnande och hudgenerande effekt och forfarande for framstellning derav
NO903281L (no) S-substituerte beta-tioakrylamider og anvendelse derav sommikrobiocider.
FI943119A0 (fi) Heterosyklisellä renkaalla substituoituja bentsyyliamiinijohdannaisia retrovirusvastaisina yhdisteinä
KR910700238A (ko) 치환된 아졸, 그의 제조방법, 그를 함유하는 제형 및 살진균제로서의 그의 용도
DE69124482D1 (de) Azolylmethyloxabicyclohexane Derivate, ihre Zwischenprodukte und fungizide Zusammensetzungen
MX9204323A (es) Procedimiento para la preparacion de derivados de taxano.
IT8822677A0 (it) Procedimento di preparazione di derivati eterociclici.
IT8920570A0 (it) Procedimento di preparazione di derivati eterociclici.
IT8921908V0 (it) Struttura di tavolo ripiegabile, particolare sdutiato per pic-nic e simili